tradingkey.logo
tradingkey.logo
검색

스포크 홀딩스(SPOK) 2026년 3분기 실적 발표회: EBITDA 거의 30% 증가

Oct 30, 2026 8:09 AM
facebooktwitterlinkedin
모든 코멘트 보기(0)

스포크 홀딩스는 2026년 3분기 GAAP 순이익이 970만 달러로 전년 동기 대비 증가했다고 발표했다. 협대역 라이선스 매각 이익 등을 제외한 조정 순이익은 약 450만 달러, 조정 EBITDA는 약 860만 달러를 기록했다. 비용 절감 효과가 지속적인 R&D 투자를 상쇄하면서 조정 영업비용은 감소했다. 현금 및 현금성 자산은 3,010만 달러로 증가했으며, 경영진은 연말 현금 잔액이 2,800만 달러에서 3,200만 달러에 달할 것으로 예상한다. 회사는 2026년 연간 가이던스를 재확인하고 분기 배당 지급 방침을 유지할 계획이다.

AI 생성 요약

핵심 요약

  • 스포크 홀딩스(Spok Holdings)는 2026년 3분기 GAAP 순이익이 970만 달러(희석 주당순이익 0.46달러)로, 전년 동기의 320만 달러(희석 주당순이익 0.15달러) 대비 증가했다고 발표했다.
  • 협대역 라이선스 매각에 따른 세후 이익과 잔여 구조조정 비용을 제외한 순이익은 약 450만 달러를 기록했다. 조정 EBITDA는 전년 동기 대비 30% 가까이 증가한 860만 달러를 기록했다.
  • 지난 4월 진행된 전략적 재정비에 따른 비용 절감 효과가 지속적인 연구개발(R&D) 투자를 상쇄하면서 조정 영업비용은 8% 이상 감소한 2,610만 달러를 기록했다.
  • 소프트웨어 매출은 1,600만 달러로 전년 동기 대비 보합세를 보였다. 라이선스 매출은 30% 가까이 증가한 140만 달러, 매니지드 전문 서비스 매출은 30% 이상 증가한 240만 달러를 기록했다.
  • 완료된 협대역 라이선스 거래로 유입된 약 760만 달러에 힘입어 현금 및 현금성 자산은 3,010만 달러로 증가했다. 경영진은 연말 현금 잔액이 2,800만 달러에서 3,200만 달러에 달할 것으로 예상하고 있다.
  • 스포크는 2026년 연간 매출 및 조정 EBITDA 가이던스를 재확인하고 분기 배당 지급 방침을 유지했다. 회사는 2026년 동안 2,700만 달러 이상의 배당금을 지급할 것으로 예상하고 있다.

주요 재무 데이터

지표2026년 3분기변동 / 맥락
GAAP 순이익970만 달러2025년 3분기 320만 달러에서 증가
희석 주당순이익(EPS)0.46달러2025년 3분기 0.15달러에서 증가
조정 순이익약 450만 달러라이선스 매각 이익 및 구조조정 비용 제외
조정 EBITDA860만 달러전년 동기 대비 30% 가까이 증가
소프트웨어 매출1,600만 달러전년 동기 대비 보합
소프트웨어 라이선스 매출140만 달러전년 동기 대비 30% 가까이 증가
매니지드 전문 서비스 매출240만 달러전년 동기 대비 30% 이상 증가
무선 ARPU8.36달러전년 동기 대비 0.17달러 증가
조정 영업비용2,610만 달러2,850만 달러에서 8% 이상 감소
현금 및 현금성 자산3,010만 달러2026년 2분기 말 1,660만 달러에서 증가
공시 소프트웨어 수주잔고5,200만 달러전년 동기 대비 15% 가까이 감소
총 소프트웨어 수주잔고6,770만 달러전년 동기 대비 약 6% 감소

사업 및 영업 실적

해당 분기 동안 무선 부문의 실적 흐름이 개선되었다. 단말기 이탈 감소와 이전의 가격 조정 조치에 힘입어 전년 동기 대비 매출 감소폭이 220bp 개선되었다. ARPU는 가격 인상, 세금 및 수수료 전가, GenA 호출기 비중 확대 등에 힘입어 8.36달러로 증가했다.

영업 수주 감소에도 불구하고 소프트웨어 매출은 안정적인 수준을 유지했다. 경영진은 대형 계약의 체결 시점에 따라 분기별 수주액이 크게 달라질 수 있다고 설명했다. 마진이 높은 매니지드 서비스는 소프트웨어 매출 구성을 지속적으로 뒷받침했다.

스포크는 2026년 첫 9개월 동안 6자리 및 7자리 수 금액의 고객 계약 42건을 체결했다. 3분기 계약에는 미국 중서부의 대형 비영리 의료 시스템과의 3년 갱신 및 확장 계약, 동남부 지역의 전국 순위권 소아과 의료 시스템과의 확장 계약이 포함되었다.

회사는 첫 9개월 동안 제품 연구개발(R&D)에 2025년 대비 8% 이상 증가한 약 1,000만 달러를 투자했다. 또한 스포크는 제품 개발을 가속화하고 '스포크 케어 커넥트(Spok Care Connect)' 기능의 시장 출시 기간을 단축하며 내부 효율성을 개선하기 위해 인공지능(AI)을 도입하고 있다.

협대역 주파수 라이선스 매각 완료로 수수료 및 거래 비용을 제외하고 750만 달러 이상의 순현금이 유입되었다. 경영진은 자사의 자산 기반을 유동화할 추가적인 기회가 존재할 수 있다고 밝혔다.

경영진 가이던스

스포크는 전략적 재정비에 따른 연간 수혜 기대감과 제품 판매 파이프라인에 대한 가시성을 바탕으로 2026년 연간 매출 및 조정 EBITDA 가이던스를 재확인했다.

경영진은 라이선스 매각, 예상 운전자본 요구량 감소, 영업 실적 등을 반영해 2026년 말 현금 및 현금성 자산이 약 2,800만 달러에서 3,200만 달러에 달할 것으로 예상하고 있다.

회사는 2026년 동안 2,700만 달러 이상의 배당금을 지급할 것으로 예상하고 있다. 경영진은 현재의 배당 및 자본 배분 정책을 재확인했다.

리스크 및 관전 포인트

  • 전체 매출은 전년 동기 대비 감소했으나, 비용 절감 효과가 이를 상쇄하며 조정 EBITDA 수준에서는 실적이 개선되었다.
  • 병원 고객들의 구매 결정 기간이 길어지고 있으며, 단기적이고 유연한 계약을 선호하는 경향이 커지면서 초기 수주 금액이 감소하고 있다.
  • 공시 소프트웨어 수주잔고는 15% 가까이 감소한 5,200만 달러를 기록했다. 총 수주잔고는 약 6% 감소한 6,770만 달러로 집계되었다.
  • 공시 수주잔고에서 제외된 취소 가능한 계약상의 의무액은 1,120만 달러에서 1,570만 달러로 증가했다. 경영진은 과거 사례에 비추어 볼 때 이러한 의무가 실제로 취소된 경우는 거의 없었다고 설명했다.
  • 무선 부문의 단말기 감소는 여전히 매출의 걸림돌로 작용하고 있으나, 가격 인상과 제품 판매가 이를 부분적으로 상쇄하고 있다.
  • 경영진은 불확실한 거시경제 환경과 긴축적인 병원 예산을 지속적인 제약 요인으로 지목했다.

실적 발표 컨퍼런스 콜 전문


전체 실적 발표 컨퍼런스 콜 녹취록

경영진 발표

Operator

Greetings. Welcome to the Spok Holdings, Inc. Q3 2026 Earnings Results Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Al Galgano, Investor Relations. Thank you, Al. You may begin.

Al Galgano

Hello, everyone, and welcome. I am joined today by Vince Kelly, Chief Executive Officer; and Michael Wallace, Chief Operating Officer and Chief Financial Officer.

After a brief presentation by management, we will open up the call to your questions. But before we begin, I want to remind everyone that today's conference call may include forward-looking statements that are subject to risks and uncertainties relating to Spok's future financial and business performance. Such statements may include estimates of revenue, expenses and income as well as other predictive statements or plans, which are dependent upon future events or conditions. These statements represent the company's estimates only on the date of this conference call and are not intended to give any assurance as to actual future results.

Spok's actual results could differ materially from those anticipated in these forward-looking statements. Although these statements are based upon assumptions that the company believes to be reasonable, they are subject to risks and uncertainties. Please review the Risk Factors section relating to our operations and the business environment, which are contained in our third quarter 2026 Form 10-Q and related documents, which will be filed with the Securities and Exchange Commission. Please note that Spok assumes no obligation to update any forward-looking statements from past or present filings and conference calls.

With that, I'll turn the call over to Vince.

Vincent Kelly

Good afternoon. Thank you for joining us for our third quarter 2026 earnings call. Let me preface my comments by saying how proud I am of our Spok team and that we remain true to our mission. Since the strategic pivot we announced a few years ago, our focus has not changed. That is to grow revenue, generate cash and return capital to our stockholders. We believe that Spok has struck an excellent balance between making the necessary investments to support those goals while aligning our organization with the market demand that we are seeing.

In the third quarter, we were able to deliver a more than 200% year-over-year increase in net income, nearly 30% year-over-year increase in adjusted EBITDA and an additional 12 basis point improvement in wireless unit attrition from the already low second quarter rate as well as an increase in year-over-year wireless average revenue per unit. While driving our top line, we also continued our focus on expense management as operating expense levels fell in the third quarter and were down more than 7% from the prior year. Much of that improvement is a result of the benefits from the strategic realignment that we announced in April.

Additionally, Spok is implementing artificial intelligence to drive further operational efficiencies across the organization with a particular focus on accelerating product development time lines, reducing time to market for new Care Connect suite capabilities and other internal uses. It is important to note that our focus on expense management as one of the key drivers to generate increased cash flow does not come at the expense of our product platform as we continue to make the necessary investments in product development, sales and marketing, customer support and professional services to support the growth of our Spok Care Connect solution offerings.

The first 9 months of 2026, Spok invested nearly $10 million in product research and development, a more than 8% increase from 2025. Investments such as these are critical to creating a best-in-class product platform and to maintaining our solid industry reputation. So today, we'll provide you with a sense of how our strategic business plan is progressing. First, I'll provide a review of our third quarter sales performance. Second, I'll review a few of the recent key highlights that position our company for the future. Next, Michael Wallace, our COO and CFO, will provide a review of our third quarter financial highlights, including our financial expectations for the balance of 2026. And finally, I will conclude our prepared remarks with a brief wrap-up before opening the call up for your questions.

Amidst all the progress in continuing to create this solid financial platform and stockholder-friendly capital allocation strategy, I want to reiterate that we remain true to our mission of being a global leader in health care communications. As we remind the listeners each quarter, simply put, we deliver critical information to care teams when and where it matters most to improve patient outcomes as Spok enables smarter, faster communication throughput for our customers. And importantly, we continue to maintain our reputation as a thought leader in the health care communications space as we continue to see customer satisfaction ratings at very high levels.

In the first 3 quarters of 2026, we were able to execute 42 6-figure and 7-figure customer contracts. We are pleased with our performance this year, especially with the headwinds our team has faced in this uncertain macroeconomic environment. I'd like to highlight a couple of the notable customer agreements from the third quarter as Spok continued to strengthen relationships with long-standing customers across the health care industry.

First, Spok successfully secured a strategic 3-year renewal expansion with one of the largest nonprofit and integrated health care systems in the Midwest that is comprised of 24 hospitals and hundreds of clinics and service organizations. This agreement expands Spok's footprint and strategic value across the organization, marking another milestone in our nearly 20-year partnership and reinforces Spok's role as a trusted provider of mission-critical communications. Beyond renewing its existing Spok SmartSuite, Spok Messenger and Spok Mobile solutions, this health care system will expand deployment to additional facilities, increasing its Spok Mobile user base to approximately 4,500 users and adopt new capabilities, including Spok Facility Alerting, Epic interfacing, multi-carrier SMS messaging and Spok Care Connect reporting and dashboards.

These investments are designed to enhance enterprise-wide communication, streamline clinical workflows, strengthen operational visibility and support timelier coordinated care delivery. The new agreement also includes ongoing premium maintenance, managed services and professional services to support continued modernization and optimization of its Spok technology environment. Second, a nationally ranked pediatric health care system located in the Southeast renewed and expanded its Spok contract.

Last year, a total of 70,000 emergency department patients, making it the busiest pediatric emergency department in the Southeast and has the state's only Level 4 NICU. This new agreement includes upgrades to Spok SmartSuite, Spok Smart Web, Spok e.Notify, Spok Voice Connect as well as our reporting consulting service and Spok Academy. The renewal of this partnership for more than 20 years reinforces Spok's position in specialty health care and reflects strong customer confidence in our platform.

Spok remains committed to delivering effective solutions that enable smarter, faster clinical communication for hospitals and health care systems. Our third quarter results reflect focused execution and continued progress against our strategic priorities. With many more exciting developments planned for the remainder of 2026, we look forward to continuing to deliver our solutions that support health care organizations and their evolving communications needs.

I'd also like to take this opportunity to point out a few recent accomplishments that we believe position Spok well for the future. As you may remember, in June, we announced the entry into an agreement to sell certain narrowband spectrum licenses in our two-way paging inventory to Sensus USA, designer and manufacturer of metering and automatic meter reading products. The purchase price was $8 million with a portion of the consideration deferred until existing Spok users were migrated to alternative frequencies. The transaction was subject to approval by the Federal Communications Commission.

I am pleased to report that this transaction has fully closed with all licenses cleared for transfer. After the customary closing fees and transaction costs, we still generated in excess of $7.5 million in cash. Resultingly, cash and cash equivalents totaled in excess of $30 million at September 30, 2026. We believe that there may be additional opportunities such as this to create stockholder value through monetizing our asset base.

Also during the quarter, we announced that Spok customers include all the children's hospitals and 18 of the 20 adult hospitals named to the 2026 and 2027 U.S. News & World Report Best Hospitals Honor Roll. We congratulate these Honor Roll hospitals on their outstanding achievement. Their recognition reflects years of dedication to patient care and clinical excellence. We are grateful for the trust they place in Spok to strengthen communication across their care teams and remain committed to providing communication infrastructure that helps their teams deliver outstanding care.

Also, this is particularly important to Spok as consumers widely reference these rankings because they emphasize factors that directly impact patient care, including clinical outcomes, adherence to best practices and the quality of hospital resources.

Finally, I'd like to highlight the announcement we made last week regarding the appointment of Shiv Gopalkrishnan as Executive Vice President and General Manager. Shiv will lead Spok's engineering, product strategy and sales organization. He is an industry veteran with 25 years of experience in building and scaling health care software businesses across electronic medical records, revenue cycle management, virtual care, clinical workflow and patient engagement.

We are excited to welcome Shiv to the Spok team as he is a rare leader who combines deep product knowledge and engineering expertise with a strong commercial mindset and unwavering focus on customer outcomes. He understands what it takes to help long-standing customers move forward with confidence.

At this very critical juncture for Spok, we are bringing engineering product strategy and sales together under one experienced leader as we position Spok to move faster, serve our customers better, pursue new growth opportunities and further leverage artificial intelligence technologies.

Before I turn the call over to Mike to review our financial performance, let me briefly summarize the goals that support our critical and important mission. Our strategic goal is simple: run the business for profitable growth, generate cash flow and return that capital to stockholders. Spok has a proud legacy of creating stockholder value and returning capital through free cash flow generation, and we intend to continue that track record. Our dividend level represents a yield in excess of 10% for our stockholders, and we're proud of our legacy there and our ability and commitment to continue funding it.

Since the beginning of our strategic pivot, which started in 2022, Spok has returned approximately $125.2 million or nearly $6 per share to our stockholders in the form of our regular quarterly dividend. In fact, since we created the company in 2004, Spok has returned nearly $750 million to our stockholders either through our regular quarterly dividend, special dividends or share repurchases.

In the third quarter of 2026, our history of returning cash to our stockholders continued as we returned $6.5 million in dividends. We expect to pay dividends in excess of $27 million in 2026 and we remain committed to our dividend policy and returning capital to our stockholders. When you take into consideration our current cash balance, distribution to stockholders, share repurchases, debt repayments and acquisitions, Spok has now generated nearly $1.1 billion of free cash flow since our creation in 2004 and returned approximately 2/3 of it to our stockholders.

Our focus on maximizing cash over the long term supports the 4 major tenets of our strategy. Those are: number one, continued investment in our product platform; number two, growing our revenue base; number three, disciplined expense management; and number four, a stockholder-friendly capital allocation plan. Going forward, we believe our extensive experience operating our established communication solutions and world-class customer base will continue to create significant value for our stockholders.

Now I will turn the call over to our Chief Operating Officer and Chief Financial Officer, Mike Wallace, who will talk about financial performance and earnings guidance. Mike?

Michael Wallace

Thanks, Vince, and good afternoon, everyone. I would now like to take a few minutes and provide a recap of our third quarter 2026 financial performance, which we reported earlier today. As always, I encourage you to review our 10-Q, when filed, as it includes significantly more information about our business operations and financial performance than we will cover on this call.

Turning to our income statement. In the third quarter of 2026, GAAP net income totaled $9.7 million or $0.46 per diluted share compared to net income of $3.2 million or $0.15 per diluted share in the prior year. However, adjusting for the onetime after-tax impact of the gain on the narrowband license sale we completed this quarter and some remaining severance and restructuring expense from the strategic realignment in April, third quarter 2026 net income would have been approximately $4.5 million, up from the prior year quarter.

Also, adjusted EBITDA of $8.6 million in the third quarter of 2026 was up nearly 30% from the prior year quarter as expense reductions resulting from the strategic realignment more than offset the year-over-year decline in total revenue. Overall, a very strong quarter from a profitability perspective. With respect to wireless revenue, the year-over-year sequential quarter revenue decline improved by 220 basis points, bolstered by continued improvement in the rate of reduction in the units in service as well as the impact from previously taken pricing actions over the course of the last couple of years.

Product sales also continue to augment any losses related to units in service. Average revenue per unit, or ARPU, which totaled $8.36 and was up $0.17 from prior year levels, continues to be our primary tool in partially offsetting revenue decline from unit loss. Sustained ARPU levels have been driven by previously discussed pricing actions and to a lesser extent, incremental pass-through taxes and fees as well as an increased mix of our higher ARPU GenA pagers in use.

Turning to our software revenue for the quarter. Revenue totaled $16 million in the third quarter and was essentially flat to the prior year period despite the lower total operations bookings. License revenue totaled $1.4 million compared to $1.1 million in the same period of 2025, up nearly 30% on a year-over-year basis. As we have said consistently, software bookings are lumpy and can vary significantly from quarter-to-quarter based on the timing of larger contracts.

We also continue to see the trends we discussed last quarter. Longer decision cycles as hospital customers conduct more extensive evaluations before committing and a preference for shorter-term agreements, which lowers the initial booking value of those contracts. Given that variability, we continue to believe bookings are best evaluated over a long period rather than in any single quarter.

Additionally, the continued solid performance of professional services revenue, albeit slightly lower than last year due to the timing of some higher dollar value projects and overall backlog levels, was a key driver in third quarter software revenue levels. Specifically, managed professional services revenue of $2.4 million in the third quarter was up over 30% from revenue in the prior year quarter. We will continue to align total resources with our backlog, and we should continue to see benefit from our higher-margin managed services mix.

Third quarter adjusted operating expenses, which excludes depreciation, amortization and accretion and severance and restructuring costs totaled $26.1 million, down from $28.5 million in the prior year or more than 8%. Drilling down into the specifics, cost of revenue was down from the prior year, primarily due to the decline in operations bookings from the level that we saw in the third quarter of 2025. Increases in research and development reflect our continued investment in our product and services platform with reductions in technology operations driven by our normal practice of cost reduction in relationship to declining wireless revenues.

Selling and marketing costs decreased approximately 23% from the prior year, consistent with what we saw in the first half of the year, reflecting lower commissions and lower trade show and event expenses. And year-over-year general and administrative costs also declined by nearly 7% as a result of the expense reductions from the strategic realignment we announced in April.

Regarding our cash balances, at the end of the third quarter, they totaled $30.1 million. The sharp increase in cash and cash equivalents from the second quarter total of $16.6 million results from 2 factors. First was the impact of the sale of the narrowband licenses. After the contribution from the purchase price as well as the additional premium from the holdback from the license transfers, which Vince pointed out, is now complete, we were able to add approximately $7.6 million to our cash balances. Also, consistent with prior years, our cash balances declined in the first half of the year as a result of typical working capital needs that include items such as the payment of our short-term incentive plans and prepaid annual renewals of technology contracts.

Additionally, first half cash flow financing activities are typically higher than in the second half of the year, reflecting payments on the company's long-term incentive plans. As anticipated, cash balances increased in the third quarter due to the lower working capital needs, coupled with the strong adjusted EBITDA performance. Given the contribution from the license sale and the anticipated reduction in working capital needs throughout the remainder of the year, we anticipate that we will exit 2026 with approximately $28 million to $32 million in cash and cash equivalents.

On a final note, I'd like to address our software operations bookings backlog, which totaled $52 million at September 30, 2026, down nearly 15% from the third quarter of 2025. As a reminder, since 2024, we have reported software backlog, excluding contractual obligations that customers can cancel without significant penalty. As shown in our earnings release tables, that exclusion totaled $15.7 million this quarter compared with $11.2 million in the prior year quarter. On a gross basis, which is how we manage the business internally, backlog totaled $67.7 million, down approximately 6% from a year ago.

The growth in the excluded amount reflects how hospitals are buying today. With budgets consistently tight and technology changing quickly, customers increasingly prefer shorter terms and more flexibility over long-term commitments. That changes how our contracts are structured, but we do not believe it changes how they perform. Historically, very few of our cancelable obligations have actually been canceled, and that track record reflects the customers behind them.

As Vince mentioned earlier, we serve all 11 children's hospitals and 18 of the 20 adult hospitals on the 2026, 2027 U.S. News & World Report Best Hospitals Honor Roll with an average relationship tenure of more than 20 years. That is why we view gross backlog as the more meaningful measure of the revenue ahead of us.

So moving on to financial guidance for 2026. Based on the anticipated full year impact of the strategic realignment and our visibility into our product sales pipeline, we are reiterating our full year 2026 financial guidance estimates. The guidance ranges for revenue and adjusted EBITDA are contained in the press release that we issued earlier today.

With that said, I would now like to turn the call back over to Vince.

Vincent Kelly

Thanks, Mike. Let me reiterate our focus on the opportunity in front of us in critical communications. From a business configuration and strategy perspective, we believe we are strongly positioned to grow our franchise while returning capital to shareholders. We have advantages over the competition in our core health care software contact center space, including long-term and deep relationships with the top health care systems in the nation who continue to purchase from us on a regular basis, offering customers an integrated platform as opposed to multiple point solutions and continuing to invest in and enhance our platforms consistent with what our customers are requesting. We are a pioneer in health care communications with a best-in-class product offering and have built an industry-leading reputation over the years.

Before I open the call up to your questions, let me take a moment to enumerate Spok's significant positive attributes. As a leader in health care communications, we maintain the largest paging network in the United States. We control significant narrowband personal communication services spectrum, an asset that we have shown can be monetized. We have a blue-chip customer base of more than 2,000 hospitals. We've created a large portfolio of intellectual property via strategic R&D investments, and we continue to generate significant cash flow and return to our investors on a quarterly basis.

I'd like to take this opportunity to thank our stockholders for their continued support and want to assure you that our primary focus remains on generating cash and increasing stockholder value. We are committed to our current dividend and capital allocation policy.

That concludes our prepared remarks. So at this point, I'll ask the operator to open the call up for your questions. We'd ask you to limit your initial questions to one and a follow-up and then after that, we'll take additional questions as time allows. Operator?

Operator

[Operator Instructions]

Vincent Kelly

Operator?

Operator

We have reached the end of the question-and-answer session. I'd like to turn the floor back over to Vince Kelly for closing comments.

Vincent Kelly

Thanks, everyone, for joining us today for our third quarter earnings release. We look forward to speaking with you in February when we release our fourth quarter results. Everyone, have a great day.

Operator

This concludes today's teleconference. You may disconnect your lines at this time. Thank you for your participation.

이 문서에는 사람이 검토한 AI 생성 콘텐츠 또는 AI 번역 콘텐츠가 포함될 수 있습니다. 이는 참고용 및 전반적인 정보를 제공용으로만 제공되며 투자 조언에 해당하지 않습니다.

면책 조항: 이 웹사이트에서 제공되는 정보는 교육적이고 정보 제공을 위한 목적으로만 사용되며, 금융 또는 투자 조언으로 간주되어서는 안 됩니다.

코멘트 (0)

$ 버튼을 클릭하고, 종목 코드를 입력한 후 주식, ETF 또는 기타 티커를 연결합니다.

0/500
코멘트 가이드라인
로딩 중...

추천 기사

tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유